Jan Marsal

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 10

Top Topics

Ulcerative Colitis

Patients With Inflammatory Bowel Disease

Electronic Health Record

Top Venues

Therapeutic advances in gastroenterology

Alimentary pharmacology & therapeutics

Cancer immunology, immunotherapy : CII

European journal of medical research

This page only lists publications with an associated author ORCID identifier.

Publications

Isabella Visuri, Carl Eriksson, Sara Karlqvist, Byron Lykiardopoulos, Per Karlén, Olof Grip, Charlotte Söderman, Sven Almer, Erik Hertervig, Jan Marsal, Carolina Malmgren, Jenny Delin, Hans Strid, Mats Sjöberg, Daniel Bergemalm, Henrik Hjortswang, Jonas Halfvarson
Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study. Therapeutic advances in gastroenterology 16 (2023)
Viktoria Bergqvist, Johanna Holmgren, Daniel Klintman, Jan Marsal
Real-world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 55 (11) (2022)
Viktoria Bergqvist, Johanna Holmgren, Daniel Klintman, Jan Marsal
Editorial: intravenous to subcutaneous vedolizumab-switch without glitch! Authors' reply. Alimentary pharmacology & therapeutics 56 (2) (2022)
Viktoria Bergqvist, Johanna Holmgren, Daniel Klintman, Jan Marsal
Letter: to switch or not to switch, that is the question-author's reply. Alimentary pharmacology & therapeutics 56 (5) (2022)
Premkumar Siddhuraj, Carl-Magnus Clausson, Caroline Sanden, Manar Alyamani, Mohammad Kadivar, Jan Marsal, Joanna Wallengren, Leif Bjermer, Jonas S Erjefält
Lung Mast Cells Have a High Constitutive Expression of Carboxypeptidase A3 mRNA That Is Independent from Granule-Stored CPA3. Cells 10 (2) (2021)
Carl Eriksson, Sara Rundquist, Vyron Lykiardopoulos, Ruzan Udumyan, Per Karlén, Olof Grip, Charlotte Söderman, Sven Almer, Erik Hertervig, Jan Marsal, Jenny Gunnarsson, Carolina Malmgren, Jenny Delin, Hans Strid, Mats Sjöberg, David Öberg, Daniel Bergemalm, Henrik Hjortswang, Jonas Halfvarson, null null
Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study. Therapeutic advances in gastroenterology 14 (2021)
Viktoria Bergqvist, Mohammad Kadivar, Daniel Molin, Leif Angelison, Per Hammarlund, Marie Olin, Jörgen Torp, Olof Grip, Stefan Nilson, Erik Hertervig, Jan Lillienau, Jan Marsal
Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease. Therapeutic advances in gastroenterology 11 (2018)
Ann-Britt Löfroos, Mohammad Kadivar, Sabina Resic Lindehammer, Jan Marsal
Colorectal cancer-infiltrating T lymphocytes display a distinct chemokine receptor expression profile. European journal of medical research 22 (1) (2017)
Viktoria Bergqvist, Erik Hertervig, Peter Gedeon, Marija Kopljar, Håkan Griph, Sara Kinhult, Ana Carneiro, Jan Marsal
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis. Cancer immunology, immunotherapy : CII 66 (5) (2017)
Mohammad Kadivar, Julia Petersson, Lena M Svensson, Jan Marsal
CD8αβ+ γδ T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease. Journal of immunology (Baltimore, Md. : 1950) 197 (12) (2016)